Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 124 | $144.29 | $17,891.96 |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,769.9335 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,893.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:11 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005560 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,760 Underlying: Common Stock · 7,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:11 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 2,980 | $144.29 | $429,984.20 |
DisclosureSEC source: 0001127602-19-005560 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,338.6004 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:11 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005560 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,318.6004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · derivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 3,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,381 Underlying: Common Stock · 1,830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 905 | $144.29 | $130,582.45 |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,687 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 3,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 544 | $144.29 | $78,493.76 |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,545 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:05 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 1,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005558 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:09 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005559 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997 Underlying: Common Stock · 520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:09 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 143 | $144.29 | $20,633.47 |
DisclosureSEC source: 0001127602-19-005559 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,654 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:09 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005559 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · derivative · entry 6 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997 Underlying: Common Stock · 3,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · derivative · entry 5 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,044 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 905 | $144.29 | $130,582.45 |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · nonDerivative · entry 4 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,593 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 3,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · nonDerivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 132 | $144.29 | $19,046.28 |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,451 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:00 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005557 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 16:55 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005556 · form4.xml · derivative · entry 5 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,374 Underlying: Common Stock · 6,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 16:55 UTC |
Ratliff John DCEO, Covance Drug Development
|
Tax withholdingCommon Stock | 1,973 | $144.29 | $284,684.17 |
DisclosureSEC source: 0001127602-19-005556 · form4.xml · nonDerivative · entry 2 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,792 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 16:55 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionCommon Stock | 6,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005556 · form4.xml · nonDerivative · entry 1 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005189 · form4.xml · derivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 148 | $147.46 | $21,824.08 |
DisclosureSEC source: 0001127602-19-005189 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,972.0782 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 16.5614 shares acquired on June 29, 2018 and 21.8340 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:46 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005189 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,120.0782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 16.5614 shares acquired on June 29, 2018 and 21.8340 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:59 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005195 · form4.xml · derivative · entry 5 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,474 Underlying: Common Stock · 1,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:59 UTC |
Ratliff John DCEO, Covance Drug Development
|
Tax withholdingCommon Stock | 556 | $147.46 | $81,987.76 |
DisclosureSEC source: 0001127602-19-005195 · form4.xml · nonDerivative · entry 2 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,665 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:59 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionCommon Stock | 1,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005195 · form4.xml · nonDerivative · entry 1 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:56 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005194 · form4.xml · derivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,304 Underlying: Common Stock · 4,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:56 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 1,254 | $147.46 | $184,914.84 |
DisclosureSEC source: 0001127602-19-005194 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,774.6004 F4 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 26.2441 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. F3 · balance_after: Amount reflects annuity payments of 12,895 shares, 4,166 shares and 10 shares made by each of the reporting person's grantor retained annuity trusts to the reporting person on September 11, 2018, November 15, 2018 and November 16, 2018, respectively. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:56 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 4,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005194 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,028.6004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 26.2441 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. F3 · balance_after: Amount reflects annuity payments of 12,895 shares, 4,166 shares and 10 shares made by each of the reporting person's grantor retained annuity trusts to the reporting person on September 11, 2018, November 15, 2018 and November 16, 2018, respectively. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:53 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005193 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,211 Underlying: Common Stock · 993 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:53 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 297 | $147.46 | $43,795.62 |
DisclosureSEC source: 0001127602-19-005193 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,259 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:53 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Exercise / conversionCommon Stock | 993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005193 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:51 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 297 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005192 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517 Underlying: Common Stock · 297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:51 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 82 | $147.46 | $12,091.72 |
DisclosureSEC source: 0001127602-19-005192 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,277 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:51 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005192 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,287 Underlying: Common Stock · 247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 68 | $147.46 | $10,027.28 |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,443.9335 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 122.8283 shares acquired on June 29, 2018 and 29.1161 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:48 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 247 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005191 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,511.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 122.8283 shares acquired on June 29, 2018 and 29.1161 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:44 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 297 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005188 · form4.xml · derivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,494 Underlying: Common Stock · 297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:44 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 104 | $147.46 | $15,335.84 |
DisclosureSEC source: 0001127602-19-005188 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,133 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2019 Filed Feb 12, 2019 00:44 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005188 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| December 04, 2018 Filed Dec 7, 2018 21:17 UTC |
BELINGARD JEAN-LUCDirector
|
GrantRestricted Stock Unit · Derivative | 3,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-035566 · form4.xml · derivative · entry 1 BELINGARD JEAN-LUC · CIK 0001200845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 3,174 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · shares: Represents a one-time equity award to Mr. Belingard in recognition of the special circumstances that resulted in the expiration without exercise of a previous option award held by Mr. Belingard that he attempted to exercise. The Board determined that failure to timely exercise the prior option award did not result from any fault or intentional delay on Mr. Belingard's part but was due to a Company administrative error. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on December 4, 2019. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 15:00 UTC |
Williams R SandersDirector
|
SaleCommon Stock | 350 | $162.14 | $56,749.00 |
DisclosureSEC source: 0001127602-18-034638 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,886 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2018 Filed Feb 14, 2019 21:24 UTC |
Schechter Adam HDirector
|
GiftCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005999 · form4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,424 Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 15:54 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionNon-qualified Stock Options · Derivative | 3,700 | $0.00 Strike: $64.42 | $0.00 |
DisclosureSEC source: 0001127602-18-032374 · form4.xml · derivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,700 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 15:54 UTC |
ANDERSON KERRII BDirector
|
SaleCommon Stock | 3,700 | $163.29 | $604,161.53 |
DisclosureSEC source: 0001127602-18-032374 · form4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,095 Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 15:54 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionCommon Stock | 3,700 | $64.42 | $238,354.00 |
DisclosureSEC source: 0001127602-18-032374 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.